Aim-To study how polychlorinated biphenyls (PCBs) aVect fetal growth and the expression of the insulin-like growth factor (IGF II) gene in the mink (Mustela vison). Methods-Ten female mink were each exposed to 0.65 or 1.3 mg Clophen A50/ day, respectively, during the reproductive season. The numbers and sizes of viable fetuses were recorded. The expression of the IGF II gene was studied by northern blotting using a mink specific IGF II cDNA probe. Results-The number of viable fetuses decreased after PCB exposure in a dose dependent fashion. Expression of the IGF II gene in adult livers from PCB exposed animals was decreased, compared with control animals, in a dose dependent fashion. In contrast, IGF II expression in placentas and fetuses was unaltered. Furthermore, the maternal excretion of urinary cortisol increased in both exposed groups during the implantation period. Conclusions-Expression of the IGF II gene is downregulated by PCB exposure in the adult liver. There is also an indication that the regulation of the expression of this gene diVers between adult and fetal life. (J Clin Pathol:Mol Pathol 1998;51:43-47) 
The disastrous eVects on the population that followed the accidental alimentary intake of polychlorinated biphenyls (PCBs) in Japan in 1968 (The Yosho disease) and Taiwan in 1979 (Yu-cheng disease) demonstrated the need for reliable animal models for studying the eVects of these toxic compounds on mammals. Recent developments have shown the mink (Mustela vison) to be a suitable model animal for studies of the eVects of PCBs.
1 Its first advantage is its sensitivity to low doses of PCB, which makes it suitable as an indicator species. Second, the mink is geographically spread over the Northern hemisphere, both in Europe and America. Third, its usefulness is not only confined to studies of human disease. The mink is a fish consumer, and it can therefore be compared with aquatic mammals (most prominently the Baltic seals that share several reproductive characteristics with the mink) that suVer risk of extinction as a result of massive exposure to chemical waste. 1 Several studies have shown that exposure to PCBs causes fetal death in mink. [2] [3] [4] [5] [6] [7] [8] However, ovulation and implantation seem to be normal in mink after exposure to PCBs. 3 5 8-10 Furthermore, the excretion of urinary cortisol in pregnant, PCB exposed mink has been found to be significantly raised early in gestation. 11 Embryonic viability is dependent on adequate nutrition, growth factors, and external endocrine stimuli. The insulin-like growth factors, IGF I and IGF II, are members of a family of structurally related peptides that are important for animal development. 12 Both the IGF I and II genes are evolutionary well conserved, at least in their coding sequences, and transcripts show extensive homology between species. 13 Whereas IGF I expression can be stimulated by pituitary growth hormone, IGF-II production cannot. 14 In this study, expression of the IGF II gene was altered in PCB exposed adult mink. This is in contrast to the fetus and placenta, where IGF II expression was similar in the PCB exposed and control animals.
Material and methods

ANIMALS AND EXPERIMENTAL DESIGN
The mink is a seasonal breeder, with a breeding season that starts in late February and lasts until the end of March in the northern hemisphere. Ovulation is induced by the copulatory act. The implantation of ova is delayed and the embryo can remain in the blastocyst stage for up to 49 days postcoitus. The gestational time, including the period of delay varies from 42 to 79 days, with a mean length of 51 days. Parturition takes place in the last week of April and continues until the middle of May, with a peak from about the 3-8 May. The crown-rump length is approximately 75 mm and the weight is 10 g at birth. A prenatal mortality in early gestation of 5.8% between the 11 and 25 April and of 35.8% between the 25 April and birth is normal.
Thirty proven breeders of two year old standard, dark, female mink were housed at a private farm near Uppsala, Sweden. The animals were individually caged. Thirty mink were allocated into three groups: the control group, animals receiving 0.65 mg Clophen A50/day, and animals receiving 1.3 mg of Clophen A50/day.
The exposure started on 2 March and the mink were mated between 12 and 27 March with non-exposed males. This gives an exposure time ranging from 79 to 94 days. The feed was supplemented with PCB dissolved in peanut oil in the exposed groups, and with peanut oil only in the control group. The feed consisted of: Baltic whole cod, 30%; whole herring, 10%; herring oVal, 10%; slaughter oVal, 15%; whole hens, 8%; mink flour (barley, oats, and wheat, which are mixed, boiled, and dried), 12%; rapeseed oil, 2%; and vitamins. Water was provided ad libitum.
The animals were killed by electrical stunning and cervical dislocation in midgestation, on 21 or 24 April (28-43 days postcoitus). One animal that received 0.65 mg PCB and four animals that received 1.3 mg PCB were excluded from the evaluation because they showed no signs of implantation.
Immediately after cervical dislocation the animals were dissected and the proportion of apparently viable fetuses was recorded. The body and liver of the adults were weighed and the numbers of placentas and fetuses, and the fetal weights and lengths (crown-rump) were recorded. Samples from adult livers, placentas, and fetuses were frozen in liquid nitrogen and stored at −80°C until further analysis. Tissue samples were analysed from three animals in each exposed group and from three control animals.
PREPARATION OF THE PCB DOSE Clophen A50 (1.4 g; Bayer AG, Stockholm, Sweden) was dissolved in 5 ml of diethylether and mixed with 484 g (538.5 ml) peanut oil (Apoteksbolaget AB, Uppsala, Sweden) using a magnetic stirrer. The ether was removed in a stream of nitrogen. The final concentration was 2.6 mg of Clophen A50/ml peanut oil.
GLUCOCORTICOID MEASUREMENTS
Five mink from each group were selected randomly for glucocorticoid excretion analysis ( fig  1) . Urine aliquots (24 hour) were collected daily. All urine was collected and filtered through a membrane to remove contaminating debris. To each urine collection container, l g of boric acid was added as preservative. Samples were stored at −20°C until assay. The determination of urinary cortisol was performed as described previously. 11 The intraassay coeYcient of variation was below 10% for concentrations in the interval 18-1294 nmol/l. The inter-assay coeYcients of variation for two control samples were 16% (29.9 nmol/l) and 7% (109.4 nmol/l). Creatinine was measured by the JaVe reaction at 500 nm (Cobas Mira; HoVman LaRoche and Co, Basel, Switzerland) according to the manufacturer's instructions. The inter-assay coeYcient of variation was 1.8% (192 mmol/l).
RNA ISOLATION
Total RNA from fetal, placental, and adult liver tissue was isolated using the guanidinium thiocyanate acid phenol/chloroform protocol as described previously. 15 Poly A+ RNA was isolated from 1 mg of total RNA using a standard oligo dT cellulose purification method. 16 
NORTHERN BLOT ANALYSIS
Aliquots of 2 µg of poly A+ RNA or 20 µg of total RNA from adult livers, fetal livers, or placentas were loaded on to each lane of a 1% agarose, 2.2 M denaturing formaldehyde gel. The quantity of RNA loaded on to each column was checked by spectrophotometry followed by titration on an ethidium bromide stained minigel. Human bulk RNA containing 18S and 28S RNA provided size markers. The RNA was transferred to a biodyne A nylon membrane (Pall, London, UK) by capillary force. The probe was a 387 base pair mink cDNA fragment which covers the coding sequence for IGF II. 17 The probe was labelled with 32 P-dCTP using a multiprime labelling kit (Amersham, Amersham, UK). The filter was prehybridised, hybridised overnight in 50% formamide at 42°C, and washed at a final stringency of l× SSC (0.15 M sodium chloride, 0.015 M sodium citrate) at 55°C. The filter was exposed for 24-96 hours at −70°C. To achieve exact quantitation of IGF II expression, filters were stripped of bound probe and rehybridised with a murine 3-hydroxy 3-methyl glutaryl (HMG) CoA-reductase (pRED 10) cDNA control probe. 18 The relative intensities were determined using a Shimatzu laser scanning densitometer. The IGF II and HMG CoA reductase values were then divided to 
Results
EFFECTS OF PCB ON FETAL GROWTH AND
VIABILITY
All 10 animals in the control group showed placentation sites. In the lower dose group (0.65 mg Clophen/day), nine of 10 animals showed placentation sites, and in the higher dose group (1.3 mg Clophen/day), six of 10 animals showed placentation sites. There was no diVerence in the numbers of placentation sites between the control group and the exposed groups in implanted animals. The ranges of placentation sites, fetal death, body weights, and liver weights of the adults as well as body weights and lengths (crown-rump) of fetuses are summarised in table 1 for the three groups. It was found that the number of placentas that contained viable fetuses, as judged by macroscopical examination, decreased with increasing concentration of PCB. Moreover, when the high dose of PCB was given, the crown-rump length and the fetal weight were significantly (p < 0.025) decreased in comparison with healthy animals.
The amount of PCB consumed with the Baltic cod and herring was estimated to be 8 mg/day (a total of 0.42 mg) for both groups.
EFFECTS OF PCB ON GLUCOCORTICOID EXCRETION
Urine samples were collected from five mink in each of the three experimental groups. The urinary excretion of cortisol, adjusted for diVerences in urinary volume by simultaneous determination of urinary creatinine, is given in fig 1. It was found that on and around day 29 postcoitus, glucocorticoid excretion increased significantly in the PCB exposed animals. The increase was transient and the excretion decreased promptly.
EFFECTS OF PCB ON EXPRESSION OF THE IGF II GENE IN THE FETUS AND PLACENTA
IGF II gene expression in the fetuses, as determined by northern blotting, gave rise to multiple transcripts. The transcripts in fetuses and placentas were quantitated and found to be comparable in control and PCB exposed animals ( fig 2) .
EFFECTS OF PCB ON IGF II GENE EXPRESSION IN THE ADULT LIVER
IGF II gene expression in the adult liver gave rise to a single, 4.6 kilobase transcript (fig 2) , the concentration of which was dependent upon the PCB dose. By scanning the intensities of the northern blot bands of IGF II and the HMG CoA reductase, and calculating the relative expression of IGF II, it was possible to show a PCB dose dependent, significant decrease (p < 0.025) in expression of the IGF II gene (fig 3) .
Discussion
The cause of fetal death in relation to PCB exposure is not yet fully understood. In this study we confirm earlier reports of fetal death, without reduction in the numbers of implantation sites, in implanted PCB treated mink. [2] [3] [4] [5] [6] [7] [8] Also, in the present study, enhanced secretion of urinary cortisol were seen on and around day 29 postcoitus in both PCB exposed groups. This is in accord with a previous study, in which pregnant mink of similar age were exposed to a higher dose (2 mg/day) of Clophen A50. These animals also showed higher excretion of cortisol during early gestation 11 and higher numbers of fetal deaths, 8 as compared with both controls and the PCB exposed animals in the present study. These results indicate a causative relation between the dose of Clophen A50 and the excretion of cortisol as well as the numbers of dead fetuses. In the present study, the sizes of the IGF II transcripts in mink were in accord with those reported in a previous study. 17 The expression of the IGF II gene in adult liver was repressed by PCB exposure, while the expression in fetuses and placentas appeared to be unaltered. Transcription from the fetal IGF II promoters shortly after birth has been shown to be glucocorticoid sensitive in rodents. 19 Furthermore, injections of glucocorticoids decreased IGF II expression in the fetal rat liver. 20 These findings can be explained by the fact that several putative glucocorticoid responsive elements have been identified upstream of the rodent P3 IGF II promoter. 19 However, there is not suYcient knowledge of either the mink IGF II gene structure or its regulatory elements to allow firm conclusions. Hence, parallels between the observed downregulation of IGF II gene expression after PCB exposure and raised glucocorticoid excretion must remain speculative. The possibility that there are specific intermediaries between the binding of key steroids to their receptors and activation of the IGF II gene must also be taken into account.
It is more diYcult to purify RNA from liver tissue than from other organs and to ensure that altered gene expression in the adult liver did not reflect impaired organ function, both IGF II and HMG CoA reductase gene expression were determined. It has been recorded in several species that PCB exposure causes hepatic fatty changes and degeneration. Moreover, adult mink exposed to 2 mg Clophen A50/day during gestation display centrilobular fatty change in the liver. 21 In the same experiment, raised concentrations of alanine aminotransferase were also reported. 22 However, because expression of the HMG CoA reductase gene in the PCB exposed mink was similar to that in control animals, it is suggested that the observed downregulation of the IGF II gene does not result from hepatic lesions or RNA degradation
The mechanism by which IGF II gene expression is aVected in the adult is probably diVerent from that in the fetus. In all mammals examined so far, diVerences in the transcriptional pattern indicate separate regulatory pathways in adult and fetal life. The mechanisms utilised include alternative promoter usage as well as diVerent splicing mechanisms for the IGF II gene. 23 Unlike the IGF I gene, which in adults is regulated by pituitary growth hormone, 14 the main regulation of IGF II remains to be elucidated.
It has been shown that in the fetus and placenta, the expression of IGF I and IGF II is influenced by insulin and nutritional factors. PCBs have been reported to reduce food consumption 24 and inhibit absorption of glucose. 25 26 In the present experiment, no diVerences were found between control and exposed animals, with regard to IGF II expression in fetuses or placentas. However, IGF II expression was measured in the fetal liver rather than whole embryos.
In conclusion, this study has shown that transcription of the IGF II gene in the adult liver was repressed after exposure to Clophen A50 in a dose dependent way. In contrast, this PCB did not alter expression in fetal livers and placentas. To complete these observations, further studies are needed to characterise the regulatory elements of the mink IGF II gene and to examine how the IGF II protein is aVected by variations in the expression of IGF receptors and binding proteins.
